PL449748A1 - Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia - Google Patents

Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia

Info

Publication number
PL449748A1
PL449748A1 PL449748A PL44974824A PL449748A1 PL 449748 A1 PL449748 A1 PL 449748A1 PL 449748 A PL449748 A PL 449748A PL 44974824 A PL44974824 A PL 44974824A PL 449748 A1 PL449748 A1 PL 449748A1
Authority
PL
Poland
Prior art keywords
hypoxia
lyophilisate
fruit
prevention
cornelian cherry
Prior art date
Application number
PL449748A
Other languages
Polish (pl)
Inventor
Bartłomiej PALECZNY
Rafał SEREDYŃSKI
Adrianna Nowicka-Czudak
Wojciech ŁOPUSIEWICZ
Małgorzata WYCISZKIEWICZ
Beata PONIKOWSKA
Alicja Kucharska
Tomasz Sozański
Paulina NOWOTARSKA
Narcyz Piórecki
Bartłomiej Czarnota
Małgorzata Trocha
Beata Nowak
Agnieszka Matuszewska
Maciej DANIELEWSKI
Marta Szandruk
Dorota Szumny
Adam Szeląg
Original Assignee
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Uniwersytet Przyrodniczy we Wrocławiu
Politechnika Wrocławska
Arboretum I Zakład Fizjografii W Bolestraszycach
Uniwersytet Rzeszowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu, Uniwersytet Przyrodniczy we Wrocławiu, Politechnika Wrocławska, Arboretum I Zakład Fizjografii W Bolestraszycach, Uniwersytet Rzeszowski filed Critical Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority to PL449748A priority Critical patent/PL449748A1/en
Priority to PCT/PL2025/050071 priority patent/WO2026054665A1/en
Publication of PL449748A1 publication Critical patent/PL449748A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Przedmiotem jest liofilizat z owoców derenia jadalnego Cornus mas L. do zastosowania w zapobieganiu niedotlenieniu - hipoksji tkanek. Rozwiązanie ma zastosowanie zwłaszcza u osób aktywnych fizycznie.The subject is a freeze-dried fruit extract from the cornelian cherry (Cornus mas L.) for use in preventing tissue hypoxia. This solution is particularly useful for physically active individuals.

PL449748A 2024-09-09 2024-09-09 Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia PL449748A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL449748A PL449748A1 (en) 2024-09-09 2024-09-09 Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia
PCT/PL2025/050071 WO2026054665A1 (en) 2024-09-09 2025-09-09 Lyophilizate from cornelian cherry (cornus mas l.) fruit for use in the prevention of hypoxia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449748A PL449748A1 (en) 2024-09-09 2024-09-09 Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia

Publications (1)

Publication Number Publication Date
PL449748A1 true PL449748A1 (en) 2026-03-16

Family

ID=99014031

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449748A PL449748A1 (en) 2024-09-09 2024-09-09 Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia

Country Status (2)

Country Link
PL (1) PL449748A1 (en)
WO (1) WO2026054665A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL222598B1 (en) * 2012-08-01 2016-08-31 Akademia Medyczna Im Piastów Śląskich We Wrocławiu Use of the preparation of the proper cultivar European selected dogwood Cornus mas L. to maintain the physiological concentration and lowering lipids, particularly triglycerides
PL242411B1 (en) * 2017-04-24 2023-02-20 Arboretum I Zakl Fizjografii W Bolestraszycach Application of a cornel-tree Cornus mas L. or its tissue or the products thereof, preferably fruit extract
PL439935A1 (en) * 2021-12-21 2023-06-26 Uniwersytet Rzeszowski Preparation from cornelian cherry fruit (Cornus mas L.) for use in the treatment and/or prevention of inflammatory anemia, for reducing inflammation and improving iron management, for use as a dietary supplement or functional food additive, and a dietary supplement or functional food

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL222598B1 (en) * 2012-08-01 2016-08-31 Akademia Medyczna Im Piastów Śląskich We Wrocławiu Use of the preparation of the proper cultivar European selected dogwood Cornus mas L. to maintain the physiological concentration and lowering lipids, particularly triglycerides
PL242411B1 (en) * 2017-04-24 2023-02-20 Arboretum I Zakl Fizjografii W Bolestraszycach Application of a cornel-tree Cornus mas L. or its tissue or the products thereof, preferably fruit extract
PL439935A1 (en) * 2021-12-21 2023-06-26 Uniwersytet Rzeszowski Preparation from cornelian cherry fruit (Cornus mas L.) for use in the treatment and/or prevention of inflammatory anemia, for reducing inflammation and improving iron management, for use as a dietary supplement or functional food additive, and a dietary supplement or functional food

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PMC; Renée Morin et al."Physiological Responses to Hypoxia on Triglyceride Levels" Front Physiol . 2021 Aug 23;12:730935. doi: 10.3389/fphys.2021.730935 *

Also Published As

Publication number Publication date
WO2026054665A1 (en) 2026-03-12

Similar Documents

Publication Publication Date Title
Brummett et al. Aminoglycoside-induced hearing loss in humans
Conteas et al. Therapy for human gastrointestinal microsporidiosis.
Atlas et al. Intratympanic gentamicin titration therapy for intractable Meniere's disease
Cazzell et al. A prospective, multicenter, single-arm clinical trial for treatment of complex diabetic foot ulcers with deep exposure using acellular dermal matrix
AR024443A1 (en) INDANIL-SUBSTITUTED BENZOLCARBONAMIDS, PROCEDURES FOR THEIR PREPARATION, ITS USE AS A MEDICINAL PRODUCT AS ALSO THE PHARMACEUTICAL PREPARATIONS THAT THEY CONTAIN
CY1110690T1 (en) 4-OXOKINOLIN COMPOUNDS AND USE THESE AS INHIBITORS OF HIV INCLUSION
DOP2000000114A (en) SUBSTITUTED OXAZOLIDINONES AND ITS USE
MX2023011087A (en) AQUEOUS PHARMACEUTICAL COMPOSITION OR STABLE LYOPHILIZED PHARMACEUTICAL COMPOSITION.
PL449748A1 (en) Lyophilisate from the fruit of the cornelian cherry (Cornus mas L.) for use in the prevention of hypoxia
CY1125075T1 (en) SALVIA HAENKEI EXTRACT AS AN ACTIVE AGENT IN TISSUE RESIPHERALIZATION AND HEALING PROCESSES
WO2020170035A3 (en) Method for treatment of rosacea including patient reported outcomes thereof
EA199700150A1 (en) COMBINED TREATMENT WITH RESPECT OF HIV INFECTION USING HIV PROTASE INHIBITOR INDINAVIAR AND REVERSE TRANSCRIPTASE INHIBITOR 3TC, OPTIONALLY TOGETHER WITH AZT, ddI OR ddC
GEAP202215466A (en) Topical formulations comprising strontium and methylsulfonylmethane (msm) and methods of treatment
ECSP003859A (en) COMPOSITION FOR THE TREATMENT OF DAMAGED FABRICS
AR037496A1 (en) NOVEDOUS USE OF 2- [5- (4-FLUOROPHENYL) -3-PIRIDILMETILAMINOMETIL] -CROMANO AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS
Fulco et al. Acid suppressive therapy and the effects on protease inhibitors
Elgart Cell phone chondrodermatitis
Khalid et al. Treatment of cutaneous leishmaniasis with some local Sudanese plants (Neem, Garad & Garlic)
NO20002481L (en) Combination therapy for the treatment of AIDS
PL450121A1 (en) Pharmaceutical composition
Gulati et al. Tuberculosis of middle ear
ES2165042T3 (en) VACCINE CONTAINING THE VIRUS OF GOAT ARTHRITIS-ENCEPHALITIS AND USE FOR IMMUNOPROTECTION AGAINST HIV-1 INFECTION.
Kumar et al. A case series on isolated maxillary sinus involvement in mucormycosis
MX2022008036A (en) NEW USE OF BCG IMMUNOGENIC FORMULATION THAT EXPRESSES A RESPIRATORY SYNCYCIAL VIRUS PROTEIN AGAINST HMPV.
Pugliese et al. Skin Grafting for Orthopedic Surgery Wounds Complicated by Pyoderma Gangrenosum